The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEBI:34306     (5Z,8Z,11Z,14Z)-20- hydroxyicosa-5,8,11,14...

Synonyms: H3023_SIGMA, HMDB02344, HMDB05998, LS-63795, LMFA03060009, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of LMFA03060009


High impact information on LMFA03060009


Chemical compound and disease context of LMFA03060009


Biological context of LMFA03060009


Anatomical context of LMFA03060009


Associations of LMFA03060009 with other chemical compounds


Gene context of LMFA03060009


Analytical, diagnostic and therapeutic context of LMFA03060009


  1. Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats. Stec, D.E., Mattson, D.L., Roman, R.J. Hypertension (1997) [Pubmed]
  2. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. Gross, G.J., Falck, J.R., Gross, E.R., Isbell, M., Moore, J., Nithipatikom, K. Cardiovasc. Res. (2005) [Pubmed]
  3. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Kehl, F., Cambj-Sapunar, L., Maier, K.G., Miyata, N., Kametani, S., Okamoto, H., Hudetz, A.G., Schulte, M.L., Zagorac, D., Harder, D.R., Roman, R.J. Am. J. Physiol. Heart Circ. Physiol. (2002) [Pubmed]
  4. Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A. Guo, M., Roman, R.J., Falck, J.R., Edwards, P.A., Scicli, A.G. J. Pharmacol. Exp. Ther. (2005) [Pubmed]
  5. Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia. Yaghi, A., Bradbury, J.A., Zeldin, D.C., Mehta, S., Bend, J.R., McCormack, D.G. Am. J. Physiol. Lung Cell Mol. Physiol. (2003) [Pubmed]
  6. Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation. Kroetz, D.L., Xu, F. Annu. Rev. Pharmacol. Toxicol. (2005) [Pubmed]
  7. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Muthalif, M.M., Benter, I.F., Karzoun, N., Fatima, S., Harper, J., Uddin, M.R., Malik, K.U. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  8. Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Kauser, K., Clark, J.E., Masters, B.S., Ortiz de Montellano, P.R., Ma, Y.H., Harder, D.R., Roman, R.J. Circ. Res. (1991) [Pubmed]
  9. Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted Mice. Luria, A., Weldon, S.M., Kabcenell, A.K., Ingraham, R.H., Matera, D., Jiang, H., Gill, R., Morisseau, C., Newman, J.W., Hammock, B.D. J. Biol. Chem. (2007) [Pubmed]
  10. Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat. Blanton, A., Nsaif, R., Hercule, H., Oyekan, A. J. Hypertens. (2006) [Pubmed]
  11. Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats. Zhou, Y., Huang, H., Chang, H.H., Du, J., Wu, J.F., Wang, C.Y., Wang, M.H. J. Pharmacol. Exp. Ther. (2006) [Pubmed]
  12. Differential effect of cytochrome P-450 omega-hydroxylase inhibition on O2-induced constriction of arterioles in SHR with early and established hypertension. Kunert, M.P., Roman, R.J., Falck, J.R., Lombard, J.H. Microcirculation (New York, N.Y. : 1994) (2001) [Pubmed]
  13. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm. Roman, R.J., Renic, M., Dunn, K.M., Takeuchi, K., Hacein-Bey, L. Neurol. Res. (2006) [Pubmed]
  14. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Seubert, J.M., Zeldin, D.C., Nithipatikom, K., Gross, G.J. Prostaglandins Other Lipid Mediat. (2007) [Pubmed]
  15. Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4. Collins, X.H., Harmon, S.D., Kaduce, T.L., Berst, K.B., Fang, X., Moore, S.A., Raju, T.V., Falck, J.R., Weintraub, N.L., Duester, G., Plapp, B.V., Spector, A.A. J. Biol. Chem. (2005) [Pubmed]
  16. Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Kroetz, D.L., Huse, L.M., Thuresson, A., Grillo, M.P. Mol. Pharmacol. (1997) [Pubmed]
  17. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Ward, N.C., Puddey, I.B., Hodgson, J.M., Beilin, L.J., Croft, K.D. Free Radic. Biol. Med. (2005) [Pubmed]
  18. Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Gross, V., Schunck, W.H., Honeck, H., Milia, A.F., Kärgel, E., Walther, T., Bader, M., Inagami, T., Schneider, W., Luft, F.C. Kidney Int. (2000) [Pubmed]
  19. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. Xu, F., Falck, J.R., Ortiz de Montellano, P.R., Kroetz, D.L. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  20. 20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. Kaduce, T.L., Fang, X., Harmon, S.D., Oltman, C.L., Dellsperger, K.C., Teesch, L.M., Gopal, V.R., Falck, J.R., Campbell, W.B., Weintraub, N.L., Spector, A.A. J. Biol. Chem. (2004) [Pubmed]
  21. 20-hydroxyeicosatetraenoic acid (20-HETE) activates mouse TRPC6 channels expressed in HEK293 cells. Basora, N., Boulay, G., Bilodeau, L., Rousseau, E., Payet, M.D. J. Biol. Chem. (2003) [Pubmed]
  22. Inhibitors of cytochrome P450 4A suppress angiogenic responses. Chen, P., Guo, M., Wygle, D., Edwards, P.A., Falck, J.R., Roman, R.J., Scicli, A.G. Am. J. Pathol. (2005) [Pubmed]
  23. Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats. Ito, O., Roman, R.J. Hypertension (1999) [Pubmed]
  24. Arachidonic acid metabolites contribute to the irreversible depolarization induced by in vitro ischemia. Tanaka, E., Niiyama, S., Sato, S., Yamada, A., Higashi, H. J. Neurophysiol. (2003) [Pubmed]
  25. Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle. Yaghi, A., Sims, S.M. Am. J. Physiol. Lung Cell Mol. Physiol. (2005) [Pubmed]
  26. The myogenic response: established facts and attractive hypotheses. Schubert, R., Mulvany, M.J. Clin. Sci. (1999) [Pubmed]
  27. 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. McGiff, J.C., Quilley, J. Curr. Opin. Nephrol. Hypertens. (2001) [Pubmed]
  28. Cytochrome P-450 metabolites in endothelin-stimulated cardiac hormone secretion. Lee, S.J., Landon, C.S., Nazian, S.J., Dietz, J.R. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2004) [Pubmed]
  29. 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. Fang, X., Faraci, F.M., Kaduce, T.L., Harmon, S., Modrick, M.L., Hu, S., Moore, S.A., Falck, J.R., Weintraub, N.L., Spector, A.A. Am. J. Physiol. Heart Circ. Physiol. (2006) [Pubmed]
  30. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Gainer, J.V., Bellamine, A., Dawson, E.P., Womble, K.E., Grant, S.W., Wang, Y., Cupples, L.A., Guo, C.Y., Demissie, S., O'Donnell, C.J., Brown, N.J., Waterman, M.R., Capdevila, J.H. Circulation (2005) [Pubmed]
  31. Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase. Cheng, M.K., McGiff, J.C., Carroll, M.A. Am. J. Physiol. Renal Physiol. (2003) [Pubmed]
  32. Renal COX-2, cytokines and 20-HETE: tubular and vascular mechanisms. Ferreri, N.R., McGiff, J.C., Carroll, M.A., Quilley, J. Curr. Pharm. Des. (2004) [Pubmed]
  33. Functional expression of human heme oxygenase-1 gene in renal structure of spontaneously hypertensive rats. Goodman, A.I., Quan, S., Yang, L., Synghal, A., Abraham, N.G. Exp. Biol. Med. (Maywood) (2003) [Pubmed]
  34. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. McCarthy, E.T., Sharma, R., Sharma, M. Kidney Int. (2005) [Pubmed]
  35. CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Amaral, S.L., Maier, K.G., Schippers, D.N., Roman, R.J., Greene, A.S. Am. J. Physiol. Heart Circ. Physiol. (2003) [Pubmed]
  36. Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Maier, K.G., Henderson, L., Narayanan, J., Alonso-Galicia, M., Falck, J.R., Roman, R.J. Am. J. Physiol. Heart Circ. Physiol. (2000) [Pubmed]
  37. Effects of intrarenal infusion of 17-octadecynoic acid on renal antihypertensive mechanisms in anesthetized rabbits. Evans, R.G., Day, K.H., Roman, R.J., Hopp, K.H., Anderson, W.P. Am. J. Hypertens. (1998) [Pubmed]
  38. Inability to Upregulate Cytochrome P450 4A and 2C Causes Salt Sensitivity in Young Sprague-Dawley Rats. Sankaralingam, S., Desai, K.M., Glaeser, H., Kim, R.B., Wilson, T.W. Am. J. Hypertens. (2006) [Pubmed]
WikiGenes - Universities